Log in to save to my catalogue

Identification of Novel Bioactive Compound Derived from Rheum officinalis against Campylobacter jeju...

Identification of Novel Bioactive Compound Derived from Rheum officinalis against Campylobacter jeju...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b180c95e5ad045b5b51c7b0fe0e0bb86

Identification of Novel Bioactive Compound Derived from Rheum officinalis against Campylobacter jejuni NCTC11168

About this item

Full title

Identification of Novel Bioactive Compound Derived from Rheum officinalis against Campylobacter jejuni NCTC11168

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

Journal title

TheScientificWorld, 2020, Vol.2020 (2020), p.1-9

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

More information

Scope and Contents

Contents

Gastric diseases are increasing with the infection of Campylobacter jejuni. Late stages of infection lead to peptic ulcer and gastric carcinoma. C. jejuni infects people within different stages of their life, especially childhood, causing severe diarrhea; it infects around two-thirds of the world population. Due to bacterial resistance against stan...

Alternative Titles

Full title

Identification of Novel Bioactive Compound Derived from Rheum officinalis against Campylobacter jejuni NCTC11168

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b180c95e5ad045b5b51c7b0fe0e0bb86

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b180c95e5ad045b5b51c7b0fe0e0bb86

Other Identifiers

ISSN

2356-6140,1537-744X

E-ISSN

1537-744X

DOI

10.1155/2020/3591276

How to access this item